Cleared Traditional

K080931 - VIDAS C. DIFICILE TOXIN A & B (CDAB) ASSAY

K080931 is the FDA 510(k) clearance for VIDAS C. DIFICILE TOXIN A & B (CDAB) ASSAY by bioMerieux, Inc.. It is a Class 1 Microbiology device (product code LLH) cleared through the Traditional 510(k) pathway after a 70-day FDA review.

K080931 · bioMerieux, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2008
Decision
70d
Days
Class 1
Risk

K080931 is an FDA 510(k) clearance for the VIDAS C. DIFICILE TOXIN A & B (CDAB) ASSAY. Classified as Reagents, Clostridium Difficile Toxin (product code LLH), Class I - General Controls.

Submitted by bioMerieux, Inc. (Hazelwood, US). The FDA issued a Cleared decision on June 11, 2008 after a review of 70 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.2660 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all bioMerieux, Inc. devices

Submission Details

510(k) Number K080931 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 02, 2008
Decision Date June 11, 2008
Days to Decision 70 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d faster than avg
Panel avg: 102d · This submission: 70d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code LLH Reagents, Clostridium Difficile Toxin
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.2660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - LLH Reagents, Clostridium Difficile Toxin

All 29
Devices cleared under the same product code (LLH) and FDA review panel - the closest regulatory comparables to K080931.
SensiTox C. difficile Toxin Test
K193490 · First Light Diagnostics, Inc. · Jul 2021
XPERT C. DIFFICILE
K091109 · Cepheid · Jul 2009
C. DIFF QUIK CHEK COMPLETE
K082499 · Techlab, Inc. · Mar 2009
VIDAS C. DIFFICILE TOXIN A&B (CDAB) ASSAY, MODEL: 30 118
K072138 · bioMerieux, Inc. · Dec 2007
TOX A/B QUICK CHEK
K050891 · Techlab, Inc. · Jul 2005
IMMUNOCARD TOXINS A & B, MODEL 712050
K041003 · Meridian Bioscience, Inc. · Aug 2004